• Health & Medicine

Aromatase inhibitors cut breast cancer recurrence in younger patients

A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women. A study by Oxford University has found that aromatase inhibitors are better than tamoxifen at reducing the risk of breast cancer recurrence in both younger and older women.

11 February 2022

• Science & Technology
• Health & Medicine

Diving into our role in 50 top cancer drugs

To mark 20 years since the merger of the Cancer Research Campaign and the Imperial Cancer Research Fund, we’ve delved into the research of the charities' that led to many of the drugs in use today. To mark 20 years since the merger of the Cancer Research Campaign and the Imperial Cancer Research Fund, we’ve delved into the research of the charities' that led to many of the drugs in use today.

9 February 2022

• Policy & Insight
• Health & Medicine

Javid's war on cancer can't leave people behind

We’ve had plans before. What we need is leadership, commitment and competence. Addressing cancer inequalities and cancer prevention must be central to the plan. We’ve had plans before. What we need is leadership, commitment and competence. Addressing cancer inequalities and cancer prevention must be central to the plan.

4 February 2022

• For Researchers

Reflections from our chief clinician: The essential role of our research community

Chief clinician Charlie Swanton gives some of his personal reflections on how far research has come and why sustained investment is so important for the therapies of the future. Chief clinician Charlie Swanton gives some of his personal reflections on how far research has come and why sustained investment is so important for the therapies of the future.

4 February 2022

• For Researchers

Reflections from our chief scientist: The rise of the whole organism

Chief scientist Karen Vousden, contemplates the advances coming from cell biology and genomics and why the new frontiers of cancer research require a systems biology approach. Chief scientist Karen Vousden, contemplates the advances coming from cell biology and genomics and why the new frontiers of cancer research require a systems biology approach.

4 February 2022

• Health & Medicine

‘Levelling Up’: What should it mean for cancer?

The UK Government has set out how they'll help parts of the country to catch up on a range of measures, including health. The UK Government has set out how they'll help parts of the country to catch up on a range of measures, including health.

2 February 2022

• Health & Medicine

120 years of discovery: 10 ways we’ve changed the story for people with cancer

From a legacy of life-saving medicines to developing new tools to detect cancer, our scientists have been at the forefront of cancer research for 120 years. From a legacy of life-saving medicines to developing new tools to detect cancer, our scientists have been at the forefront of cancer research for 120 years.

2 February 2022

• Health & Medicine

Immunotherapy treatment fast tracked to treat lung cancer patients in England

Hope for patients with early-stage lung cancer as new treatment approved for use on NHS England. Hope for patients with early-stage lung cancer as new treatment approved for use on NHS England.

28 January 2022

• Charity News
• Personal Stories

Atlantic rowing trio smash world record and raise thousands for cancer charities

A British woman with an incurable cancer has broken the world record for rowing across the Atlantic, raising thousands for Cancer Research UK. A British woman with an incurable cancer has broken the world record for rowing across the Atlantic, raising thousands for Cancer Research UK.

24 January 2022

• Policy & Insight

Opinion: “We’ve been pushing for change for 20 years. We’re not stopping now”

This year marks 20 years of Cancer Research UK. A chance to reflect on the incredible advances we’ve made and a reminder of how much we have left to achieve. This year marks 20 years of Cancer Research UK. A chance to reflect on the incredible advances we’ve made and a reminder of how much we have left to achieve.

24 January 2022

• For Researchers
• Science & Technology

Seven Centres to form new Cancer Research UK network

From 1 April, we’re investing £100 million over five years into seven Cancer Research UK Centres across the UK. From 1 April, we’re investing £100 million over five years into seven Cancer Research UK Centres across the UK.

24 January 2022